"Het Universitair Ziekenhuis Antwerpen is een universitair centrum voor topklinische en klantvriendelijke patiëntenzorg, hoogwaardige academische opleiding en grensverleggend wetenschappelijk onderzoek met een belangrijke internationale dimensie. Gespecialiseerde artsen en zorgverleners omringen elke patiënt met een persoonlijke aanpak en innovatieve technieken en behandelingen."

During the past decade, Antwerp University Hospital conducted 272 clinical trials. In the 10-year time frame, 272 clinical trials started and 40 clinical trials were completed, i.e. on average, 14.7% percent of trials that started reached the finish line to date. In the past 5 years, 131 clinical trials started and 36 clinical trials were completed. i.e. 27.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Antwerp University Hospital" #1 sponsor was "University Hospital, Antwerp" with 125 trials, followed by "Universiteit Antwerpen" with 22 trials sponsored, "FLUIDDA nv" with 11 trials sponsored, "Universitaire Ziekenhuizen KU Leuven" with 11 trials sponsored and "University Hospital, Ghent" with 11 trials sponsored. Other sponsors include 194 different institutions and companies that sponsored additional 164 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Antwerp University Hospital" #1 collaborator was "University Hospital, Antwerp" with 34 trials as a collaborator, "Universiteit Antwerpen" with 25 trials as a collaborator, "Universitaire Ziekenhuizen KU Leuven" with 9 trials as a collaborator, "Universitair Ziekenhuis Brussel" with 8 trials as a collaborator and "University Hospital, Ghent" with 8 trials as a collaborator. Other collaborators include 413 different institutions and companies that were collaborators in the rest 334 trials.

According to Clinical.Site data, the most researched conditions in "Antwerp University Hospital" are "Obstructive Sleep Apnea" (9 trials), "Tinnitus" (9 trials), "Asthma" (7 trials), "Breast Cancer" (7 trials) and "Chronic Obstructive Pulmonary Disease" (6 trials). Many other conditions were trialed in "Antwerp University Hospital" in a lesser frequency.

Most popular intervention types in "Antwerp University Hospital" are "Drug" (156 trials), "Device" (73 trials), "Other" (66 trials), "Procedure" (39 trials) and "Biological" (23 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (31 trials), "Functional Respiratory Imaging" (4 trials), "Gemcitabine" (4 trials), "Pembrolizumab" (4 trials) and "placebo" (4 trials). Other intervention names were less common.

The vast majority of trials in "Antwerp University Hospital" are 340 trials for "All" genders, 29 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are 120 active trials in "Antwerp University Hospital". 2 are not yet recruiting, 85 are recruiting, 30 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 169 completed trials in Antwerp University Hospital, 1 suspended trials, and 34 terminated clinical trials to date.

Out of the total trials that were conducted in Antwerp University Hospital, 29 "Phase 1" clinical trials were conducted, 76 "Phase 2" clinical trials and 65 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 33 trials, and there were also 114 trials that are defined as “Not Applicable".